Navigation Links
New Blood Test Advances Individualized Cancer Therapy and Cuts Down on Need for Painful Biopsies
Date:7/24/2014

Bethesda, MD (PRWEB) July 24, 2014

The first-ever successful isolation and culture of rare tumor cells circulating in a patient’s blood has been achieved by NFCR-supported scientist Daniel Haber, M.D., Ph.D., and his team at Massachusetts General Hospital. This is an important milestone on the road to individualized cancer therapy, a new approach to selecting the best treatment for each patient.

“Tumors evolve in response to treatment,” said Dr. Haber. “They often acquire new genetic features that make them resistant to drugs. If we can monitor those changes in real time, we stand a better chance of matching the right treatments with the right patients against those new changes in their tumors.” With the success of the CTC-iChip, it is now possible to do just that.

The CTC-iChip is a business card-sized device developed by MGH bioengineer Dr. Mehmet Toner, Dr. Haber and their collaborators that can capture extraordinarily rare “circulating tumor cells” (CTCs) from a patient’s blood sample – one tumor cell per billion blood cells. Recent improvements in the chip make it easier to remove CTCs from the filter device and grow them in cell culture dishes in the labs.

As part of the experiment, the researchers took multiple blood samples from women with breast cancer over the course of their treatment, and were able to monitor the development of new mutations in their CTCs. Because this approach starts with a simple blood test, changes in the tumor cells can be assessed over time without the need for repeated, invasive, and painful biopsies.

Using the CTC-derived tumor models grown in the lab, Dr. Haber’s team could also test various combinations of drugs to see which were effective. This technique could provide a new way to help physicians develop personalized cancer treatment plans for individual patients. Dr. Haber and his team are now focused on optimizing CTC culture conditions, improving efficiency, bringing down costs, and meeting the remaining challenges to bring individualized therapy into the clinic.

“At NFCR we take the long view of cancer research, and our support of Dr. Haber’s research over the past decade is paying off,” said Franklin Salisbury, Jr., President of NFCR. “We could not be more proud of what Dr. Haber and his colleagues at MGH have accomplished, and we have every confidence that they will continue to improve this technique, making individualized therapy a reality for cancer patients everywhere.”

Dr. Haber has received NFCR support since 2003. Dr. Haber’s findings were published in the July 11 issue of the journal Science.

About the National Foundation for Cancer Research

The National Foundation for Cancer Research (NFCR) is a leading cancer research charity dedicated to funding cancer research and public education relating to cancer prevention, earlier diagnosis, better treatments and, ultimately, a cure for cancer. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside. NFCR is committed to Research for a Cure - cures for all types of cancer. For more information, visit http://www.nfcr.org/ or call (800) 321-CURE (2873).

Read the full story at http://www.prweb.com/releases/2014/07/prweb12042342.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Infection Might Raise Blood Clot Risk for Older Adults: Study
2. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
3. Common Blood Pressure Drug Safe for Heart Failure: Study
4. Certain Birth Control Pills May Carry Higher Blood Clot Risk: FDA
5. High Blood Pressure May Be Especially Lethal for Blacks
6. Changes in gene expression may help explain high blood pressure in pregnancy
7. Researchers Develop Blood Test for Depression
8. Naturopathic care can improve blood sugar, mood in diabetes
9. Diabetes Groups Issue New Guidelines on Blood Sugar
10. Exercise May Help Patients With High Blood Pressure Live Longer
11. Additional blood pressure screening may reduce incidence of CVD events and death by up to 3 percent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... 2017 , ... Loyale Healthcare today announced the ... joins other recent high-profile hires including Frank Massi, Chief Revenue Officer and Shirley ... helping physician practices and hospitals automate their clinical and financial processes to gain ...
(Date:8/23/2017)... ... , ... The Stevie® Awards have announced the winners of the Best of the IBA Awards ... competition. , Nominees in the 2017 IBAs were not able to apply for the Best ... total number of awards won in the IBAs with a Gold Stevie win counting for ...
(Date:8/23/2017)... Indiana (PRWEB) , ... August 23, 2017 , ... ... Whitney Boling, MD , has returned home to Indiana, and is now seeing ... is a board-eligible ophthalmologist that specializes in the diagnosis and treatment of eye ...
(Date:8/23/2017)... ... August 23, 2017 , ... A new literature ... Surgeons , points out that therapeutic modalities (physical therapy) is an important part ... the report, a wider scope of physical therapy options is showing promising results ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... Medicine recently spoke at a popular international aesthetics conference for medical professionals about ... restoring his patients’ health and his growing practice. , Dr. George K. ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... MJAC2017 , the premier cannabis event devoted ... reveals its leading lineup. MJAC2017 is ... innovator specializing in the development of pharmaceutical and consumer products, ... and The Green Organic Dutchman are gold sponsors for the ... sponsors. ...
(Date:8/15/2017)... POINT, N.C. , Aug. 15, 2017  Axium Pharmaceuticals Inc., the ... is rumored to be in the beginning stages of an IPO. ... annually on epilepsy medications with the average cost of a prescription epilepsy ... ... Another staggering figure is the ...
(Date:8/10/2017)... 2017  Physical Rehabilitation Network (PRN), acquired the long-standing outpatient ... Colorado . The reputable clinic will continue to be ... with his staff of four clinicians. Lipkin received his doctorate ... over 10 years of experience with a strong background in ... marks the 10th PRN clinic in and around the ...
Breaking Medicine Technology: